The Brazil in vitro diagnostics market was valued at USD 4.90 Billion in 2025, driven by the rising chronic diseases, elderly population and demand for non-invasive diagnostic technologies and tools in the region. The market is anticipated to grow at a CAGR of 5.80% during the forecast period of 2026-2035, with the values likely to reach USD 8.61 Billion by 2035. Robust healthcare reforms and expanding private laboratories are fueling diagnostic growth, while government initiatives enhance accessibility. Rising demand for molecular diagnostics and point-of-care testing is expected to drive adoption during the forecast period.
Base Year
Historical Period
Forecast Period
In October 2024, PATH and Bio-Manguinhos/Fiocruz launched a collaboration to boost local production and innovation in Brazil’s in vitro diagnostics, strengthening regional capacity for vaccines, diagnostics, and health equity.
The market is propelled by the escalating prevalence of chronic diseases like diabetes, cardiovascular conditions, and cancer. Additionally, the aging population and advancements in molecular diagnostics are further fueling market growth
Key trends shaping Brazil's in vitro diagnostics market include the integration of artificial intelligence and automation in diagnostic processes, the rise of personalized medicine, and the increasing adoption of point-of-care testing solutions.
Compound Annual Growth Rate
5.8%
Value in USD Billion
2026-2035
*this image is indicative*
In vitro diagnostics (IVD) are medical tests conducted on specimens such as blood, urine, or tissue, outside the human body to detect, monitor, or assess health conditions. These diagnostics are essential for accurate disease detection, treatment decisions, and overall patient management across various healthcare disciplines. The market is witnessing significant growth and is poised to grow at a CAGR of 5.80% during the forecast period of 2026–2035. It is driven by rising healthcare expenditures, increased emphasis on early disease detection, and the integration of advanced diagnostic technologies. Enhanced government initiatives and public-private collaborations further contribute to market expansion.
Rising Chronic Disease Burden Among the Aging Population to Accelerate the Market Growth
The growing prevalence of chronic diseases among Brazil’s elderly population is a major driver in the market. As highlighted by Wanderley Matos Reis Júnior et al. March 2024 study, approximately 70% of Brazilians aged 60 and older are affected by at least one chronic illness, such as diabetes, cardiovascular disease, or hypertension. This significant health burden not only increases the demand for regular monitoring and early disease detection but also emphasizes the critical role of diagnostic testing in preventive and therapeutic healthcare. Consequently, the market in Brazil is expected to witness substantial growth.
Some of the notable trends in the market are the enhancement of regulatory frameworks and the increasing adoption of genomics alongside advanced data analytics.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Segmentation Based on Application to Witness Substantial Growth
In the dynamic landscape of Brazil’s healthcare sector, the in vitro diagnostics market is divided into key applications such as infectious diseases, diabetes, oncology, cardiology, drug testing, HIV/AIDS, autoimmune disorders, nephrology, and more. Infectious diseases are expected to lead the market, driven by the need for rapid and accurate diagnostics to manage widespread health concerns. According to the Pan American Health Organization 2024 report, Brazil recorded 41 new tuberculosis cases per 100,000 population in 2022, with a mortality rate of 2.2 per 100,000 in 2019. Additionally, the HIV infection incidence rate was 19.5 per 100,000 population in 2021, supporting increased demand for infectious disease diagnostics.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
F. Hoffmann-La Roche Ltd., headquartered in Basel, Switzerland and established in 1896, is a global leader in in vitro diagnostics. It provides a wide range of diagnostic tests, instruments, and digital solutions for diseases such as cancer, diabetes, COVID-19, and hepatitis. Their innovative laboratory and near-patient diagnostic systems support efficient, high-quality disease detection and patient management across Brazilian healthcare settings.
Founded in 1952 and headquartered in Hercules, California, Bio-Rad Laboratories, Inc. plays a significant role in the in vitro diagnostics market. The company offers QXDx Droplet Digital PCR (ddPCR) systems and CE-IVD-approved kits, including the AutoDG System and BCR-ABL %IS Kit, which support high-precision diagnostics and disease monitoring, particularly in oncology and genetic testing.
bioMérieux SA is a global leader in in vitro diagnostics. The company actively supports regulatory initiatives such as the EU In Vitro Diagnostic Regulation (IVDR) and offers a wide range of diagnostic solutions for infectious diseases and clinical testing. In Brazil, bioMérieux contributes significantly to advancing laboratory diagnostics, providing high-quality, regulation-compliant products that enhance disease detection and patient care.
Abbott, headquartered in Illinois, United States, is a healthcare and diagnostics player. Abbott plays a key role with its Architect i1000SR immunoassay analyzer. This system delivers high-throughput testing with enhanced workflow efficiency and is designed for in vitro diagnostic use, supporting clinical decision-making with reliable and rapid results.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Thermo Fisher Scientific Inc., Qiagen, Quidel Corporation, and Danaher Corporation.
Upto 15% Off
USD
$3099 $2789
$1999 $1799
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share